Participant safety is one of the most important responsibilities in clinical research. Even when a study is considered low risk, researchers must have procedures for identifying, documenting, evaluating, and responding to unexpected health problems. A key part of this process is adverse event tracking.
An adverse event is generally any unfavorable medical occurrence that happens while someone is participating in a study. Importantly, an adverse event does not necessarily mean that the study caused the problem. Researchers document these events so they can evaluate potential relationships, identify patterns, and determine whether additional safety measures are necessary.
Adverse events can range considerably in severity. They may include new symptoms, abnormal laboratory findings, illnesses, injuries, or worsening of an existing condition.
For example, a participant in a nutrition study might report nausea, headaches, digestive discomfort, or another symptom during the intervention period. Researchers must determine whether the event could be related to the study intervention, an existing medical condition, another medication or supplement, or an unrelated cause.
Researchers typically evaluate an event based on several factors, including its severity, expectedness, timing, and possible relationship to study participation.
A serious adverse event receives additional attention. These events can include death, life-threatening conditions, hospitalization, significant disability, congenital anomalies, or medical situations requiring intervention to prevent a serious outcome.
Adverse event monitoring begins with clear procedures established before participants are enrolled. Study protocols typically explain how researchers will collect safety information and what actions should be taken when an event occurs.
Information can come directly from participants during study visits, phone calls, questionnaires, or other scheduled communications. Researchers may also identify potential adverse events through laboratory results, physical examinations, medical records, or other study assessments.
Participants play an important role in this process. They should receive instructions about which symptoms or changes in health to report and how to contact the research team between scheduled visits.
Once researchers learn about an adverse event, the details must be documented carefully. This can include when the event began, its severity, how long it lasted, any treatment required, its outcome, and whether the research team believes it may be related to study participation.
Researchers also evaluate whether an adverse event was expected based on the study protocol and known information about the intervention.
This distinction is particularly important when an event is unexpected and potentially related to the research. Under federal human-subject protection guidance, certain unexpected events that suggest participants face greater risks than previously recognized may qualify as unanticipated problems requiring prompt reporting to an Institutional Review Board (IRB) and other appropriate entities.
Tracking an adverse event is only part of the process. Researchers must also determine whether action is necessary to protect participants.
Depending on the circumstances, researchers may increase participant monitoring, adjust eligibility requirements, modify study procedures, update informed consent materials, pause enrollment, or suspend certain research activities. Serious or unexpected findings can also lead to broader reviews of study safety data.
Safety monitoring is therefore an ongoing process rather than a single checkpoint. By consistently documenting and evaluating adverse events, research teams can identify potential concerns early, respond appropriately, and help protect participants throughout the entire study.
Biofortis is dedicated to protecting consumer health throughout the world by delivering a wide range of testing and consultancy services to the food, supplement, and nutrition industries. Biofortis supports this mission in two ways–through clinical trials and sensory and consumer insights testing. We specialize in clinical research targeting foods, ingredients, and dietary supplements that affect body structures, function, and overall health. Contact us with any clinical trial or scientific consulting needs.